Shuhui Liu

5PUBLICATIONS

47CO-AUTHORS

Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Sep 09, 2026

Discovery and Optimization of AMT-676, a CDH17-Targeting ADC for the Treatment of Advanced Gastrointestinal Cancers.

|Apr 17, 2026

ADCE-T02 - a Next Generation Antibody Drug Conjugate Targeting Tissue Factor Demonstrates Superior Preclinical Efficacy and Tolerability.

|Sep 05, 2023

A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting Melanoma.

Jing Shi, Tao Jiao, Qian Guo

|Jun 11, 2023

AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors.

Weining Weng, Tao Meng, Junyi Pu

|Jan 24, 2023

Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer.

Weining Weng, Tao Meng, Qianqian Zhao

Pageof 1

Frequent Collaborators

Xun Meng

Jianjian Zhang

Weining Weng

Tao Meng

Lijun Wang

Wenhao Hu

Caiwei Chen

Mingqiao Wang

Rong Pan

Linjie Ma

Frequent Collaborators

Xun Meng

Jianjian Zhang

Weining Weng

Tao Meng